Hyloris Developmentsen (Belgium) Performance
| HYL Stock | EUR 6.32 0.02 0.32% |
Hyloris Developmentsen has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.95, which attests to possible diversification benefits within a given portfolio. Hyloris Developmentsen returns are very sensitive to returns on the market. As the market goes up or down, Hyloris Developmentsen is expected to follow. Hyloris Developmentsen right now retains a risk of 3.94%. Please check out Hyloris Developmentsen standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Hyloris Developmentsen will be following its current trending patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Hyloris Developmentsen Sa are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak essential indicators, Hyloris Developmentsen may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 64.4 M | |
| Total Cashflows From Investing Activities | -3.1 M |
Hyloris |
Hyloris Developmentsen Relative Risk vs. Return Landscape
If you would invest 600.00 in Hyloris Developmentsen Sa on December 26, 2024 and sell it today you would earn a total of 32.00 from holding Hyloris Developmentsen Sa or generate 5.33% return on investment over 90 days. Hyloris Developmentsen Sa is generating 0.1559% of daily returns assuming 3.9425% volatility of returns over the 90 days investment horizon. Simply put, 35% of all stocks have less volatile historical return distribution than Hyloris Developmentsen, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Hyloris Developmentsen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hyloris Developmentsen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hyloris Developmentsen Sa, and traders can use it to determine the average amount a Hyloris Developmentsen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0395
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HYL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Hyloris Developmentsen is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hyloris Developmentsen by adding it to a well-diversified portfolio.
Hyloris Developmentsen Fundamentals Growth
Hyloris Stock prices reflect investors' perceptions of the future prospects and financial health of Hyloris Developmentsen, and Hyloris Developmentsen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hyloris Stock performance.
| Return On Equity | -0.22 | |||
| Return On Asset | -0.0973 | |||
| Operating Margin | (3.33) % | |||
| Current Valuation | 309.43 M | |||
| Shares Outstanding | 28 M | |||
| Price To Book | 6.06 X | |||
| Price To Sales | 118.47 X | |||
| Revenue | 3.1 M | |||
| EBITDA | (10.59 M) | |||
| Cash And Equivalents | 53.48 M | |||
| Cash Per Share | 2.08 X | |||
| Total Debt | 300 K | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 1.86 X | |||
| Cash Flow From Operations | (11.25 M) | |||
| Earnings Per Share | (0.45) X | |||
| Total Asset | 63.44 M | |||
About Hyloris Developmentsen Performance
Assessing Hyloris Developmentsen's fundamental ratios provides investors with valuable insights into Hyloris Developmentsen's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Hyloris Developmentsen is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Hyloris Pharmaceuticals SA manufactures pharmaceutical products. Hyloris Pharmaceuticals SA was founded in 2013 and is based in Liege, Belgium. HYLORIS is traded on Brussels Stock Exchange in Belgium.Things to note about Hyloris Developmentsen performance evaluation
Checking the ongoing alerts about Hyloris Developmentsen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hyloris Developmentsen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hyloris Developmentsen had very high historical volatility over the last 90 days | |
| Hyloris Developmentsen has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.1 M. Net Loss for the year was (11.58 M) with profit before overhead, payroll, taxes, and interest of 2.99 M. | |
| Hyloris Developmentsen Sa has accumulated about 53.48 M in cash with (11.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08. | |
| Roughly 52.0% of the company shares are held by company insiders |
- Analyzing Hyloris Developmentsen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hyloris Developmentsen's stock is overvalued or undervalued compared to its peers.
- Examining Hyloris Developmentsen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hyloris Developmentsen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hyloris Developmentsen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hyloris Developmentsen's stock. These opinions can provide insight into Hyloris Developmentsen's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Hyloris Stock Analysis
When running Hyloris Developmentsen's price analysis, check to measure Hyloris Developmentsen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hyloris Developmentsen is operating at the current time. Most of Hyloris Developmentsen's value examination focuses on studying past and present price action to predict the probability of Hyloris Developmentsen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hyloris Developmentsen's price. Additionally, you may evaluate how the addition of Hyloris Developmentsen to your portfolios can decrease your overall portfolio volatility.